These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20653459)

  • 1. New antibiotic structures from fermentations.
    Singh SB; Young K
    Expert Opin Ther Pat; 2010 Oct; 20(10):1359-71. PubMed ID: 20653459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The historical delivery of antibiotics from microbial natural products--can history repeat?
    Peláez F
    Biochem Pharmacol; 2006 Mar; 71(7):981-90. PubMed ID: 16290171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products to drugs: daptomycin and related lipopeptide antibiotics.
    Baltz RH; Miao V; Wrigley SK
    Nat Prod Rep; 2005 Dec; 22(6):717-41. PubMed ID: 16311632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical antibacterial drug discovery--foundation in natural products.
    Singh SB; Barrett JF
    Biochem Pharmacol; 2006 Mar; 71(7):1006-15. PubMed ID: 16412984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of natural products as a source of new antibiotics.
    Luzhetskyy A; Pelzer S; Bechthold A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):608-13. PubMed ID: 17668363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD.
    Eisenstein BI; Oleson FB; Baltz RH
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S10-5. PubMed ID: 20067387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products--the future scaffolds for novel antibiotics?
    Butler MS; Buss AD
    Biochem Pharmacol; 2006 Mar; 71(7):919-29. PubMed ID: 16289393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.
    Carpenter CF; Chambers HF
    Clin Infect Dis; 2004 Apr; 38(7):994-1000. PubMed ID: 15034832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
    Steenbergen JN; Alder J; Thorne GM; Tally FP
    J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin structure and mechanism of action revealed.
    Micklefield J
    Chem Biol; 2004 Jul; 11(7):887-8. PubMed ID: 15271343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F; Beiras-Fernandez A; Schelling G
    Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation mechanisms underlying the biosynthesis of daptomycin and related lipopeptides.
    Liao G; Shi T; Xie J
    J Cell Biochem; 2012 Mar; 113(3):735-41. PubMed ID: 22020738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics.
    Miao V; Coëffet-Le Gal MF; Nguyen K; Brian P; Penn J; Whiting A; Steele J; Kau D; Martin S; Ford R; Gibson T; Bouchard M; Wrigley SK; Baltz RH
    Chem Biol; 2006 Mar; 13(3):269-76. PubMed ID: 16638532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin.
    Kirkpatrick P; Raja A; LaBonte J; Lebbos J
    Nat Rev Drug Discov; 2003 Dec; 2(12):943-4. PubMed ID: 14756140
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening strategies for discovery of antibacterial natural products.
    Singh SB; Young K; Miesel L
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Daptomycin: revitalizing a former drug due to the need of new active agents against grampositive multiresistant bacterias].
    Hernández Martí V; Romá Sánchez E; Salavert Lletí M; Bosó Ribelles V; Poveda Andrés JL
    Rev Esp Quimioter; 2007 Sep; 20(3):261-76. PubMed ID: 18080024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.
    Kanafani ZA; Corey GR
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):177-84. PubMed ID: 17402833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2004 Sep; 18(3):651-68, x. PubMed ID: 15308280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin in the treatment of skin, soft-tissue and invasive infections due to Gram-positive bacteria.
    Johnson A
    Future Microbiol; 2006 Oct; 1(3):255-65. PubMed ID: 17661638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.